Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
J Biochem (Tokyo). 1995 Jun;117(6):1244-53. Unique Identifier : AIDSLINE MED/96104996 Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H; Division of Enzyme Chemistry, University of Tokushima.
Abstract:
We recently purified the calcium-independent processing protease named viral envelope glycoprotein maturase (VEM), that converts human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein precursor gp160 to gp120 and gp41, from the human CD4+ T cell line, Molt-4 clone 8 [Kido, H., Kamoshita, K., Fukutomi, A., and Katunuma, N. (1993) J. Biol. Chem. 268, 13406-13413]. In this report, we deal with the inhibitor specificity and calcium requirement for intracellular gp160 processing in cultured HeLa cells and human CD4+ lymphocytes. Processing of gp160 in these cells infected with recombinant vaccinia virus encoding the gp160 gene was not affected by intracellular calcium depletion induced by the calcium ionophore A23187 and EGTA or by intracellular calcium administration. Processing of gp160 by the purified VEM in vitro was not inhibited by EDTA, EGTA, or the metallo-protease inhibitor phosphoramidon, but was specifically inhibited by a substrate analog, decanoyl-RVKR-chloromethylketone, and the trypsin-type protease inhibitors aprotinin, HI-30, and diisopropyl fluorophosphate (DFP). It was also inhibited by E-64 and thiol reagents. But intracellular gp160 processing was inhibited only by permeable, low molecular mass inhibitors of VEM, such as DFP, E-64, and thiol reagents. Syncytium formation induced by cell surface gp120 was also inhibited by permeable inhibitors of VEM. Taken together, our results indicate that calcium ions may not be essential for intracellular gp160 processing and so HIV-1 gp160 induced by recombinant vaccinia virus may be processed mainly by a protease(s) that does not require calcium ions, such as VEM in these cells.
Keywords: Amino Acid Sequence Aniline Compounds Calcimycin/PHARMACOLOGY Calcium/*METABOLISM/PHARMACOLOGY CD4-Positive T-Lymphocytes/*METABOLISM Egtazic Acid/PHARMACOLOGY Fluorescent Dyes Gene Products, env/GENETICS/*METABOLISM Giant Cells/METABOLISM Glycoside Hydrolases/METABOLISM Hela Cells Human *HIV-1/GENETICS Kinetics Microscopy, Phase-Contrast Molecular Sequence Data Peptide Peptidohydrolases/*METABOLISM Protease Inhibitors/CHEMISTRY/PHARMACOLOGY Protein Precursors/GENETICS/*METABOLISM *Protein Processing, Post-Translational Recombinant Proteins/METABOLISM Sulfhydryl Reagents/PHARMACOLOGY Support, Non-U.S. Gov't Vaccinia Virus Xanthenes JOURNAL ARTICLE 960330
M9630692
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
